Science
B.C. particle accelerator scores triumph with deal to produce ‘rarest drug on earth’ – q107.com
UBC’s TRIUMF facility is gearing up to produce actinium-225, a rare radioisotope that early research shows could have a powerful effect fighting cancer.
A team at the Canada’s particle accelerator facility at the University of British Columbia is celebrating a major triumph, inking a deal to produce a rare cancer drug that previously relied on nuclear waste.
The TRIUMF project has formed a partnership with Ontario-based Fusion Pharmaceuticals to upgrade its facility to produce actinium-225, nicknamed “the rarest drug on Earth.”
Read more: BWXT Peterborough touts ‘tremendous progress’ in medical isotope production at Darlington nuclear station
That…
-
General22 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General23 hours agoLithium mine closure shines light on Ravensthorpe community’s resilience
-
Noosa News22 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News24 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland